跳至主要内容
临床试验/NL-OMON49126
NL-OMON49126尚未招募不适用

Osteochondral lesions under 15mm2 of the Talus; is iliac crest Bone marrow Aspirate Concentrate the Key to success? - OUTBACK trial

Academisch Medisch Centrum0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with a symptomatic OCL of the talus who are scheduled for
  • arthroscopic debridement and microfracture
  • OCL depth and/or diameter <= 15 mm on computed tomography medial-lateral
  • and/or anterior-posterior
  • Age 18 years or older
  • Intact remaining articular cartilage of the joint Kellgren-Lawrence stage 0-1

排除标准

  • Concomitant OCL of the tibia
  • Ankle osteoarthritis grade 2 or 3
  • Ankle fracture < 6 months before scheduled arthroscopy
  • Inflammatory arthropathy (e.g Rheumatoid arthritis)
  • History of (or current) hemopoeitic disease or immunotherapy
  • Acute or chronic instability of the ankle
  • Use of prescribed orthopaedic shoewear
  • Other concomitant painful or disabling disease of the lower limb
  • Pregnancy
  • Implanted pacemaker
  • Participation in previous trials < 1 year, in which the subject has been
  • exposed to radiation (radiographs or CT)
  • Patients who are unable to fill out questionnaires and cannot have them
  • No informed consent
  • HIV positive or hepatitis B or C infection (based on the anamnesis of the

研究者

相似试验

Osteochondral lesions under 15mm2 of the Talus; is... | 临床试验